vs

Side-by-side financial comparison of Core Scientific, Inc. (CORZ) and RHYTHM PHARMACEUTICALS, INC. (RYTM). Click either name above to swap in a different company.

Core Scientific, Inc. is the larger business by last-quarter revenue ($79.8M vs $57.3M, roughly 1.4× RHYTHM PHARMACEUTICALS, INC.). Core Scientific, Inc. runs the higher net margin — 268.5% vs -83.0%, a 351.5% gap on every dollar of revenue. On growth, RHYTHM PHARMACEUTICALS, INC. posted the faster year-over-year revenue change (36.9% vs -16.0%). Over the past eight quarters, RHYTHM PHARMACEUTICALS, INC.'s revenue compounded faster (48.5% CAGR vs -33.3%).

Core Scientific is a leading digital asset and high-performance computing infrastructure provider. It operates large energy-efficient data centers across North America, offering cryptocurrency mining services, colocation hosting for blockchain and AI clients, and custom high-performance computing solutions for enterprise tech segments.

Rhythm Pharmaceuticals is a biopharmaceutical firm focused on developing and commercializing targeted therapies for rare genetic disorders causing severe unmanageable obesity, including POMC deficiency, LEPR deficiency, and Bardet-Biedl syndrome. It serves patients in North America and Europe who lack effective standard treatments for their chronic life-altering conditions.

CORZ vs RYTM — Head-to-Head

Bigger by revenue
CORZ
CORZ
1.4× larger
CORZ
$79.8M
$57.3M
RYTM
Growing faster (revenue YoY)
RYTM
RYTM
+52.8% gap
RYTM
36.9%
-16.0%
CORZ
Higher net margin
CORZ
CORZ
351.5% more per $
CORZ
268.5%
-83.0%
RYTM
Faster 2-yr revenue CAGR
RYTM
RYTM
Annualised
RYTM
48.5%
-33.3%
CORZ

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CORZ
CORZ
RYTM
RYTM
Revenue
$79.8M
$57.3M
Net Profit
$214.2M
$-47.5M
Gross Margin
26.0%
91.6%
Operating Margin
-149.5%
-82.2%
Net Margin
268.5%
-83.0%
Revenue YoY
-16.0%
36.9%
Net Profit YoY
180.6%
-9.6%
EPS (diluted)
$-1.63
$-0.73

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CORZ
CORZ
RYTM
RYTM
Q4 25
$79.8M
$57.3M
Q3 25
$81.1M
$51.3M
Q2 25
$78.6M
$48.5M
Q1 25
$79.5M
$32.7M
Q4 24
$94.9M
$41.8M
Q3 24
$95.4M
$33.3M
Q2 24
$141.1M
$29.1M
Q1 24
$179.3M
$26.0M
Net Profit
CORZ
CORZ
RYTM
RYTM
Q4 25
$214.2M
$-47.5M
Q3 25
$-144.0M
$-52.9M
Q2 25
$-936.8M
$-46.6M
Q1 25
$576.3M
$-49.5M
Q4 24
$-265.5M
$-43.3M
Q3 24
$-455.3M
$-43.6M
Q2 24
$-902.2M
$-32.3M
Q1 24
$210.7M
$-141.4M
Gross Margin
CORZ
CORZ
RYTM
RYTM
Q4 25
26.0%
91.6%
Q3 25
4.8%
89.3%
Q2 25
6.4%
88.6%
Q1 25
10.3%
88.8%
Q4 24
5.0%
90.9%
Q3 24
-0.2%
88.5%
Q2 24
27.5%
89.9%
Q1 24
43.3%
89.2%
Operating Margin
CORZ
CORZ
RYTM
RYTM
Q4 25
-149.5%
-82.2%
Q3 25
-67.6%
-102.6%
Q2 25
-33.4%
-93.4%
Q1 25
-59.1%
-143.7%
Q4 24
-41.9%
-98.6%
Q3 24
-43.2%
-132.0%
Q2 24
-64.3%
-139.2%
Q1 24
30.8%
-538.7%
Net Margin
CORZ
CORZ
RYTM
RYTM
Q4 25
268.5%
-83.0%
Q3 25
-177.6%
-103.1%
Q2 25
-1191.4%
-96.1%
Q1 25
724.6%
-151.4%
Q4 24
-279.7%
-103.6%
Q3 24
-477.4%
-131.2%
Q2 24
-639.4%
-110.9%
Q1 24
117.5%
-544.4%
EPS (diluted)
CORZ
CORZ
RYTM
RYTM
Q4 25
$-1.63
$-0.73
Q3 25
$-0.45
$-0.82
Q2 25
$-0.04
$-0.75
Q1 25
$1.24
$-0.81
Q4 24
$0.51
$-0.71
Q3 24
$-1.17
$-0.73
Q2 24
$-5.05
$-0.55
Q1 24
$0.78
$-2.35

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CORZ
CORZ
RYTM
RYTM
Cash + ST InvestmentsLiquidity on hand
$311.4M
$388.9M
Total DebtLower is stronger
Stockholders' EquityBook value
$-962.7M
$139.1M
Total Assets
$2.3B
$480.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CORZ
CORZ
RYTM
RYTM
Q4 25
$311.4M
$388.9M
Q3 25
$453.4M
$416.1M
Q2 25
$581.3M
$291.0M
Q1 25
$697.9M
$314.5M
Q4 24
$836.2M
$320.6M
Q3 24
$253.0M
$298.4M
Q2 24
$96.1M
$319.1M
Q1 24
$98.1M
$201.2M
Stockholders' Equity
CORZ
CORZ
RYTM
RYTM
Q4 25
$-962.7M
$139.1M
Q3 25
$-1.3B
$148.8M
Q2 25
$-1.2B
$-11.9M
Q1 25
$-308.8M
$18.9M
Q4 24
$-943.0M
$21.7M
Q3 24
$-826.7M
$11.2M
Q2 24
$-1.2B
$39.3M
Q1 24
$-318.5M
$61.6M
Total Assets
CORZ
CORZ
RYTM
RYTM
Q4 25
$2.3B
$480.2M
Q3 25
$2.2B
$506.9M
Q2 25
$1.9B
$372.7M
Q1 25
$1.5B
$386.7M
Q4 24
$1.5B
$392.3M
Q3 24
$824.6M
$363.6M
Q2 24
$664.2M
$381.8M
Q1 24
$814.0M
$258.7M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CORZ
CORZ
RYTM
RYTM
Operating Cash FlowLast quarter
$278.3M
$-25.4M
Free Cash FlowOCF − Capex
$-450.8M
FCF MarginFCF / Revenue
-565.1%
Capex IntensityCapex / Revenue
914.0%
Cash ConversionOCF / Net Profit
1.30×
TTM Free Cash FlowTrailing 4 quarters
$-779.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CORZ
CORZ
RYTM
RYTM
Q4 25
$278.3M
$-25.4M
Q3 25
$131.8M
$-26.6M
Q2 25
$34.0M
$-23.3M
Q1 25
$-45.0M
$-40.4M
Q4 24
$42.9M
$-18.8M
Q3 24
$5.7M
$-25.2M
Q2 24
$1.2M
$-29.1M
Q1 24
$22.2M
$-40.7M
Free Cash Flow
CORZ
CORZ
RYTM
RYTM
Q4 25
$-450.8M
Q3 25
$-112.7M
Q2 25
$-87.3M
Q1 25
$-129.0M
Q4 24
$-52.1M
Q3 24
$-25.5M
Q2 24
$-1.9M
Q1 24
$-9.7M
FCF Margin
CORZ
CORZ
RYTM
RYTM
Q4 25
-565.1%
Q3 25
-139.0%
Q2 25
-111.0%
Q1 25
-162.2%
Q4 24
-54.8%
Q3 24
-26.7%
Q2 24
-1.4%
Q1 24
-5.4%
Capex Intensity
CORZ
CORZ
RYTM
RYTM
Q4 25
914.0%
Q3 25
301.5%
Q2 25
154.2%
Q1 25
105.6%
Q4 24
100.0%
Q3 24
32.7%
Q2 24
2.2%
Q1 24
17.8%
Cash Conversion
CORZ
CORZ
RYTM
RYTM
Q4 25
1.30×
Q3 25
Q2 25
Q1 25
-0.08×
Q4 24
Q3 24
Q2 24
Q1 24
0.11×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CORZ
CORZ

Other$36.3M46%
Digital Asset Self Mining Service$31.8M40%
Colocation Service$11.6M15%

RYTM
RYTM

Segment breakdown not available.

Related Comparisons